Stockholders' Equity - Additional Information (Details)
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
Jan. 01, 2024
shares
|
Oct. 04, 2023
USD ($)
|
Jan. 01, 2023
shares
|
Oct. 31, 2024
USD ($)
|
Oct. 31, 2023
USD ($)
$ / shares
shares
|
Jul. 31, 2023
USD ($)
$ / shares
shares
|
May 31, 2023
USD ($)
$ / shares
shares
|
Apr. 30, 2023
USD ($)
$ / shares
shares
|
Feb. 28, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2023
USD ($)
multiplier
Vote
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Nov. 30, 2023
shares
|
Mar. 31, 2023
USD ($)
|
Nov. 03, 2022
$ / shares
shares
|
Nov. 02, 2022
shares
|
Nov. 30, 2020
USD ($)
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
9,586,683
|
27,042,035
|
9,586,683
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
50,000,000
|
80,000,000
|
50,000,000
|
|
|
80,000,000
|
30,000,000
|
|
Common stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
9,586,683
|
27,042,035
|
9,586,683
|
|
|
|
|
|
Shelf registration statement, maximum authorized securities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000,000
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
|
$ 5.25
|
|
|
|
|
|
|
|
|
Net proceeds of common stock issued | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 9,872,000
|
|
|
|
|
|
Issuance of common shares - Founders agreement | $ |
|
|
|
|
|
|
|
|
|
|
$ 952,000
|
418,000
|
|
|
|
|
|
Proceeds from Warrant | $ |
|
|
|
|
|
|
|
|
|
|
11,134,000
|
|
|
|
|
|
|
Payment of transactional costs for exercise of warrants | $ |
|
|
|
|
|
|
|
|
|
|
1,016,000
|
|
|
|
|
|
|
Warrant inducement expense | $ |
|
|
|
|
|
|
|
|
|
|
|
1,200,000
|
|
|
|
|
|
Loss on common stock warrant liabilities | $ |
|
|
|
|
|
|
|
|
|
|
217,000
|
(4,451,000)
|
|
|
|
|
|
Deemed dividends | $ |
|
|
|
|
|
|
|
|
|
|
$ 7,500,000
|
$ 0
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
110,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
|
|
1,134,000
|
|
6,215,354
|
|
|
|
|
Total unrecognized compensation cost related to non-vested | $ |
|
|
|
|
|
|
|
|
|
|
$ 2,400,000
|
|
|
|
|
|
|
Common stock shares issuable |
|
|
|
|
|
|
|
|
|
368,907
|
1,492,915
|
368,907
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
$ 1.76
|
|
|
|
|
$ 4.33249
|
|
$ 4.33249
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 7,500,000
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 6,700,000
|
|
|
|
|
|
Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
|
|
4.325
|
|
$ 4.325
|
|
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
|
|
|
|
|
|
950,000
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
$ 3.0899
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
|
Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
1,428,572
|
1,734,105
|
|
1,734,105
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.075
|
|
$ 4.075
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|
|
|
Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
|
1,734,105
|
|
1,734,105
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.075
|
|
$ 4.075
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
|
|
18 months
|
|
18 months
|
|
|
|
|
|
Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
|
104,046
|
|
104,046
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 5.406
|
|
$ 5.406
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 800,000
|
|
|
|
|
|
Non-vested restricted stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average period (in years) |
|
|
|
|
|
|
|
|
|
|
1 year 10 months 24 days
|
|
|
|
|
|
|
Performance Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock outstanding non-vested |
|
|
|
|
|
|
|
|
|
|
186,733
|
|
|
|
|
|
|
2015 Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000,000
|
13,500,000
|
|
Number of shares available for issuance authorized |
|
|
|
|
|
|
|
|
|
6,000,000
|
|
6,000,000
|
|
|
3,000,000
|
900,000
|
|
Plans expires (in years) |
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
Shares are available for issuance |
|
|
|
|
|
|
|
|
|
|
3,510,830
|
|
|
|
|
|
|
At the market offering (ATM) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds of common stock issued | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 9,900,000
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
|
|
|
|
|
$ 0
|
10,120,000
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 248,000
|
|
|
|
|
|
February 2023 Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
|
$ 5.25
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
|
|
248,572
|
|
|
|
|
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
|
|
|
1,180,000
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
|
|
|
$ 7,500,000
|
|
|
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
|
|
|
|
|
6,700,000
|
|
|
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
|
|
|
$ 800,000
|
|
|
|
|
|
|
|
|
February 2023 Registered Direct Offering | Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
|
$ 5.2499
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
|
|
248,572
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
Warrants offering price | $ / shares |
|
|
|
|
|
|
|
|
$ 5.2499
|
|
|
|
|
|
|
|
|
February 2023 Registered Direct Offering | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
1,428,572
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
February 2023 Registered Direct Offering | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
1,428,572
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
|
February 2023 Registered Direct Offering | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
85,714
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 6.5625
|
|
|
|
|
|
|
|
|
April 2023 Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
$ 3.60
|
|
|
|
|
|
|
|
|
|
Shelf registration statement remaining authorized securities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000,000
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
|
|
1,700,000
|
|
|
|
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
|
|
$ 6,100,000
|
|
|
|
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
|
|
|
|
5,500,000
|
|
|
|
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
|
|
$ 600,000
|
|
|
|
|
|
|
|
|
|
April 2023 Direct Offering | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
1,700,000
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
$ 3.35
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
April 2023 Direct Offering | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
1,700,000
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
$ 3.35
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
|
|
April 2023 Direct Offering | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
102,000
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
$ 4.50
|
|
|
|
|
|
|
|
|
|
December 2022 direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.325
|
|
$ 4.325
|
|
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
|
|
|
|
950,000
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
$ 4.075
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
|
|
|
|
$ 7,500,000
|
|
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
|
|
|
|
|
|
6,700,000
|
|
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
|
|
|
|
$ 800,000
|
|
|
|
|
|
|
|
December 2022 direct offering | Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
|
|
|
784,105
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.3249
|
|
4.3249
|
|
|
|
|
|
December 2022 direct offering | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.075
|
|
$ 4.075
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|
|
|
December 2022 direct offering | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.075
|
|
$ 4.075
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
|
|
|
18 months
|
|
18 months
|
|
|
|
|
|
December 2022 direct offering | Maximum | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
|
1,734,105
|
|
1,734,105
|
|
|
|
|
|
December 2022 direct offering | Maximum | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
|
|
|
1,734,105
|
|
1,734,105
|
|
|
|
|
|
May 2023 Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
$ 3.071
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
1,606,269
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
|
1,650,000
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
$ 3.0709
|
|
|
|
|
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
|
$ 10,000,000.0
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
|
|
|
9,100,000
|
|
|
|
|
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
|
$ 900,000
|
|
|
|
|
|
|
|
|
|
|
May 2023 Registered Direct Offering | Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
1,606,269
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
Warrants offering price | $ / shares |
|
|
|
|
|
|
3.0709
|
|
|
|
|
|
|
|
|
|
|
May 2023 Registered Direct Offering | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
$ 2.821
|
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
May 2023 Registered Direct Offering | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
$ 2.821
|
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
|
|
|
May 2023 Registered Direct Offering | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
195,376
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
|
$ 3.8388
|
|
|
|
|
|
|
|
|
|
|
May 2023 Registered Direct Offering | Maximum | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
3,256,269
|
|
|
|
|
|
|
|
|
|
|
May 2023 Registered Direct Offering | Maximum | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
|
3,256,269
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
$ 3.09
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
2,427,186
|
|
|
|
|
|
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
|
$ 10,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
|
|
9,100,000
|
|
|
|
|
|
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
|
$ 900,000
|
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering | Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
809,062
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
809,062
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
Warrants offering price | $ / shares |
|
|
|
|
|
3.0899
|
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
$ 2.84
|
|
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
3,236,248
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
$ 2.84
|
|
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
194,175
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
|
$ 3.8625
|
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering | Maximum | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
3,236,248
|
|
|
|
|
|
|
|
|
|
|
|
July 2023 Registered Direct Offering | Maximum | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
|
3,236,248
|
|
|
|
|
|
|
|
|
|
|
|
October 2023 Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from Warrant | $ |
|
|
|
|
$ 11,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment of transactional costs for exercise of warrants | $ |
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
6,325,354
|
|
|
|
|
|
1,134,000
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
$ 1.76
|
|
|
|
$ 5.00
|
$ 4.075
|
|
$ 4.075
|
|
|
|
|
|
Total gross proceeds from Issuance of common stock | $ |
|
|
|
|
$ 11,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from offering | $ |
|
|
|
$ 10.0
|
10,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of commissions and other transaction costs | $ |
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2023 Registered Direct Offering | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
$ 1.51
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2023 Registered Direct Offering | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
6,325,354
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
$ 1.51
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration term of warrants (in years) |
|
|
|
|
24 months
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2023 Registered Direct Offering | Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
379,521
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrants exercise price | $ / shares |
|
|
|
|
$ 2.20
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2023 Registered Direct Offering | Maximum | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
6,325,354
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2023 Registered Direct Offering | Maximum | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued and sold to purchase shares |
|
|
|
|
6,325,354
|
|
|
|
|
|
|
|
|
|
|
|
|
December 2022 Common Stock Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on common stock warrant liabilities | $ |
|
$ (7,700,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 2023 Common Stock Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant inducement expense | $ |
|
|
|
|
|
|
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
Deemed dividends | $ |
|
|
|
|
|
|
|
|
|
|
6,300,000
|
|
|
|
|
|
|
Fortress |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common shares - Founders agreement | $ |
|
|
|
|
|
|
|
|
|
|
1,000,000.0
|
$ 400,000
|
|
|
|
|
|
Shelf registration statement remaining authorized securities | $ |
|
|
|
|
|
|
|
|
|
|
$ 91,700,000
|
|
|
|
|
|
|
Percentage of annual equity fee |
2.50%
|
|
2.50%
|
|
|
|
|
|
|
|
2.50%
|
|
|
|
|
|
|
Common stock shares issuable |
1,492,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued and sold |
1,492,915
|
|
368,907
|
|
|
|
|
|
|
|
398,660
|
56,671
|
|
|
|
|
|
Agent | At the market offering (ATM) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commission rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00%
|
Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of votes per share | Vote |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
Multiplier to calculate voting rights per class A common share | multiplier |
|
|
|
|
|
|
|
|
|
|
1.1
|
|
|
|
|
|
|
Number of non assessable shares issued upon conversion |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
Common stock shares issued during the period under at the market offering |
|
|
|
|
|
|
|
|
|
|
|
532,816
|
|
|
|
|
|
Common Stock | At the market offering (ATM) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock shares issued during the period under at the market offering |
|
|
|
|
|
|
|
|
|
|
|
532,816
|
|
|
|
|
|
Aggregate gross proceeds of common stock issued | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 10,100,000
|
|
|
|
|
|
Purchase price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 18.99
|
|
$ 18.99
|
|
|
|
|
|
Common Stock | July 2023 Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued and sold |
|
|
|
|
|
2,427,186
|
|
|
|
|
|
|
|
|
|
|
|
Share price | $ / shares |
|
|
|
|
|
$ 3.09
|
|
|
|
|
|
|
|
|
|
|
|
Common Class A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
700,000
|
700,000
|
700,000
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
700,000
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
700,000
|
700,000
|
700,000
|
|
|
|
|
|